ArticleCancer research2026

RAS-GTP Inhibition Overcomes Acquired Resistance to KRASG12C Inhibitors Mediated by Oncogenic and Wild-Type RAS Activation in Non-Small Cell Lung Cancer.

Hitendra S Solanki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.